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Sensory nerve Amplitude V 
Right median  Absent 
Right ulnar Absent 
Right radial Absent 
Right sural Absent 
Right superficial peroneal Absent 
Left sural Absent 
 
Motor nerve DML ms CV m/s  MAP mV  F wave latency/ms 
Right median 6.2 37 2.4 42.5 
Right ulnar (ADM) 4.1 42 8.3 33.5 
Right common peroneal (EDB) NR NR NR NR 
Right posterior  7.0 - 0.4 61.7 
 
Supplementary table 1. The nerve conduction parameters of a patient with autosomal 
recessive spastic ataxia of Charlevoix Saguenay (ARSACS). DML = distal motor latency; CV = 
conduction velocity; MAP = motor action potential; ADM = abductor digiti minimi, EDB = 
extensor digitorum brevis. 
 
 
Sensory nerve Amplitude V 
Right median  Absent 
Right ulnar Absent 
Right radial Absent 
Right sural Absent 
Right superficial peroneal Absent 
 
Motor nerve DML ms CV m/s  MAP mV  F wave latency/ms 
Right median 6.8 37 5.7 43 
Right ulnar (ADM) 6.6 32 4.4 53 
Right common peroneal (EDB) 13.4 32 1.8 - 
Right posterior tibial 7.3 26 1.4 77 
 
Supplementary table 2. The nerve conduction parameters of a patient with a demyelinating 
neuropathy that is sometimes seen with familial amyloid polyneuropathy due to autosomal 
dominant mutations in TTR. DML = distal motor latency; CV = conduction velocity; MAP = 
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